REATA PHARMACEUTICALS INC Research and Development Expense
REATA PHARMACEUTICALS INC reported Research and Development Expense of $57.12 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-08
- REATA PHARMACEUTICALS INC research and development expense for the quarter ending 2023-06-30 was $57.12M, a 45.23% increase year-over-year.
- REATA PHARMACEUTICALS INC research and development expense for the quarter ending 2023-03-31 was $55.48M, a 39.38% increase year-over-year.
- REATA PHARMACEUTICALS INC research and development expense for the quarter ending 2022-12-31 was $47.22M, a 13.47% increase year-over-year.
- REATA PHARMACEUTICALS INC research and development expense for the quarter ending 2022-09-30 was $43.48M, a 10.28% increase year-over-year.
- REATA PHARMACEUTICALS INC research and development expense for fiscal 2022 was $169.84M, a 8.88% increase from fiscal 2021.
- REATA PHARMACEUTICALS INC research and development expense for fiscal 2021 was $155.99M, a 1.94% decline from fiscal 2020.
- REATA PHARMACEUTICALS INC research and development expense for fiscal 2020 was $159.08M, a 24.18% increase from fiscal 2019.
- REATA PHARMACEUTICALS INC research and development expense for fiscal 2019 was $128.11M, a 31.68% increase from fiscal 2018.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $57.12M 10-Q · filed 2023-08-08 | $112.60M 10-Q · filed 2023-08-08 | $159.82M derived: sum of 3 quarters · filed 2023-08-08 | $203.31M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $55.48M 10-Q · filed 2023-05-10 | $102.70M derived: sum of 2 quarters · filed 2023-05-10 | $146.19M derived: sum of 3 quarters · filed 2023-05-10 | $185.52M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $47.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $90.71M derived: sum of 2 quarters · filed 2023-02-24 | $130.04M derived: sum of 3 quarters · filed 2023-08-08 | $169.84M 10-K · filed 2023-02-24 |
| 2022-09-30 | $43.48M 10-Q · filed 2022-11-08 | $82.82M derived: sum of 2 quarters · filed 2023-08-08 | $122.62M 10-Q · filed 2022-11-08 | $164.24M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $39.33M 10-Q · filed 2023-08-08 | $79.14M 10-Q · filed 2023-08-08 | $120.75M derived: sum of 3 quarters · filed 2023-08-08 | $160.18M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $39.80M 10-Q · filed 2023-05-10 | $81.42M derived: sum of 2 quarters · filed 2023-05-10 | $120.85M derived: sum of 3 quarters · filed 2023-05-10 | $160.92M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $41.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $81.05M derived: sum of 2 quarters · filed 2023-02-24 | $121.11M derived: sum of 3 quarters · filed 2023-02-24 | $155.99M 10-K · filed 2023-02-24 |
| 2021-09-30 | $39.43M 10-Q · filed 2022-11-08 | $79.50M derived: sum of 2 quarters · filed 2022-11-08 | $114.38M 10-Q · filed 2022-11-08 | $151.84M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $40.07M 10-Q · filed 2022-08-08 | $74.95M 10-Q · filed 2022-08-08 | $112.41M derived: sum of 3 quarters · filed 2023-02-24 | $149.59M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $34.88M 10-Q · filed 2022-05-10 | $72.34M derived: sum of 2 quarters · filed 2023-02-24 | $109.52M derived: sum of 3 quarters · filed 2023-02-24 | $146.31M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $37.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $74.64M derived: sum of 2 quarters · filed 2023-02-24 | $111.43M derived: sum of 3 quarters · filed 2023-02-24 | $159.08M 10-K · filed 2023-02-24 |
| 2020-09-30 | $37.18M 10-Q · filed 2021-11-08 | $73.97M derived: sum of 2 quarters · filed 2021-11-08 | $121.62M 10-Q · filed 2021-11-08 | $161.78M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $36.78M 10-Q · filed 2021-08-09 | $84.44M 10-Q · filed 2021-08-09 | $124.60M derived: sum of 3 quarters · filed 2022-02-28 | $156.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $47.65M 10-Q · filed 2021-05-06 | $87.81M derived: sum of 2 quarters · filed 2022-02-28 | $120.09M derived: sum of 3 quarters · filed 2022-02-28 | $149.65M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $40.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $72.44M derived: sum of 2 quarters · filed 2022-02-28 | $101.99M derived: sum of 3 quarters · filed 2022-02-28 | $128.11M 10-K · filed 2022-02-28 |
| 2019-09-30 | $32.28M 10-Q · filed 2020-11-09 | $61.83M derived: sum of 2 quarters · filed 2020-11-09 | $87.95M 10-Q · filed 2020-11-09 | $113.26M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $29.55M 10-Q · filed 2020-08-10 | $55.67M 10-Q · filed 2020-08-10 | $80.98M derived: sum of 3 quarters · filed 2021-03-01 | $108.12M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $26.11M 10-Q · filed 2020-05-11 | $51.42M derived: sum of 2 quarters · filed 2021-03-01 | $78.57M derived: sum of 3 quarters · filed 2021-03-01 | $102.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $25.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $52.45M derived: sum of 2 quarters · filed 2021-03-01 | $75.88M derived: sum of 3 quarters · filed 2021-03-01 | $97.29M 10-K · filed 2021-03-01 |
| 2018-09-30 | $27.14M 10-Q · filed 2019-11-12 | $50.57M derived: sum of 2 quarters · filed 2019-11-12 | $71.98M 10-Q · filed 2019-11-12 | $92.42M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $23.43M 10-Q · filed 2019-08-08 | $44.84M 10-Q · filed 2019-08-08 | $65.28M derived: sum of 3 quarters · filed 2020-02-19 | $83.61M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $21.41M 10-Q · filed 2019-05-09 | $41.85M derived: sum of 2 quarters · filed 2020-02-19 | $60.18M derived: sum of 3 quarters · filed 2020-02-19 | $78.08M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $20.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $38.77M derived: sum of 2 quarters · filed 2020-02-19 | $56.67M derived: sum of 3 quarters · filed 2020-02-19 | $71.27M 10-K · filed 2020-02-19 |
| 2017-09-30 | $18.33M 10-Q · filed 2018-11-07 | $36.23M derived: sum of 2 quarters · filed 2018-11-07 | $50.83M 10-Q · filed 2018-11-07 | $62.60M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $17.90M 10-Q · filed 2018-08-08 | $32.50M 10-Q · filed 2018-08-08 | $44.28M derived: sum of 3 quarters · filed 2019-02-28 | $53.58M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $14.60M 10-Q · filed 2018-05-08 | $26.38M derived: sum of 2 quarters · filed 2019-02-28 | $35.67M derived: sum of 3 quarters · filed 2019-02-28 | $44.75M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $11.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $21.07M derived: sum of 2 quarters · filed 2019-02-28 | $30.15M derived: sum of 3 quarters · filed 2019-02-28 | $39.45M 10-K · filed 2019-02-28 |
| 2016-09-30 | $9.30M 10-Q · filed 2017-11-13 | $18.38M derived: sum of 2 quarters · filed 2017-11-13 | $27.68M 10-Q · filed 2017-11-13 | $36.01M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-06-30 | $9.07M 10-Q · filed 2017-08-14 | $18.38M 10-Q · filed 2017-08-14 | $26.71M derived: sum of 3 quarters · filed 2018-03-02 | $35.26M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-03-31 | $9.31M 10-Q · filed 2017-05-10 | $17.63M derived: sum of 2 quarters · filed 2018-03-02 | $26.18M derived: sum of 3 quarters · filed 2018-03-02 | $35.87M derived: sum of 4 quarters · filed 2018-03-02 |
| 2015-12-31 | $8.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $16.88M derived: sum of 2 quarters · filed 2018-03-02 | $26.56M derived: sum of 3 quarters · filed 2018-03-02 | $35.14M 10-K · filed 2018-03-02 |
| 2015-09-30 | $8.55M 10-Q · filed 2016-11-14 | $18.24M derived: sum of 2 quarters · filed 2016-11-14 | $26.82M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $9.69M 10-Q · filed 2016-08-11 | $18.27M 10-Q · filed 2016-08-11 | ||
| 2014-12-31 | $34.30M 10-K · filed 2017-03-03 |